Quarterly report pursuant to Section 13 or 15(d)

Common Stock Equivalents (Details)

v3.19.3
Common Stock Equivalents (Details) - shares
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 7,724,808 4,383,429
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 2,137,665 1,364,859
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 626,343 728,493
Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 4,960,800 2,290,077